The list of tier 1 assets RRL could have acquired over the years with its strong cashflow is staggering...
- Cowal
- Jundee- Carose Dam- Thunderbox- KOTH- SuperPit- NorsemanI'm probably forgetting a few... When those opportunities presented itself, RRL was too much in its comfort zone to do anything about it. In business you can't have that mindframe. A large part of business is taking on opportunities when it presents itself. The other mid-tiers have grown their production ounces via the boardroom over the years. RRL never touched this lever until recently.
I did add more today too. Let's see what the next 3 years will bring. If we can get McPhils going within that timeframe great. Another operational asset in North America would be nice as a currency diversifier. But hey Rome was not built in a day; and per-tropicana, at least RRL is taking steps to the M&A growth of the business they sorely lacked over the years. Expensive as it is, I'll even call that acquisition turning over a new leaf for the better...
- Forums
- ASX - By Stock
- RRL
- Under valued
Under valued, page-590
-
- There are more pages in this discussion • 639 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RRL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$2.46 |
Change
-0.100(3.91%) |
Mkt cap ! $1.858B |
Open | High | Low | Value | Volume |
$2.44 | $2.50 | $2.43 | $9.899M | 4.018M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 11739 | $2.46 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$2.47 | 45405 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 14794 | 2.450 |
7 | 137921 | 2.440 |
8 | 270426 | 2.430 |
3 | 3291 | 2.420 |
2 | 10380 | 2.410 |
Price($) | Vol. | No. |
---|---|---|
2.470 | 45405 | 6 |
2.480 | 92394 | 3 |
2.490 | 91109 | 3 |
2.500 | 32860 | 4 |
2.510 | 5140 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
RRL (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online